Literature DB >> 33649167

Targeting cancer with bispecific antibodies.

Jon Weidanz1.   

Abstract

Entities:  

Year:  2021        PMID： 33649167     DOI： 10.1126/science.abg5568

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

Review 1.  Novel classes of immunotherapy for breast cancer.

Authors:  Alberto Hernando-Calvo; David W Cescon; Philippe L Bedard
Journal:  Breast Cancer Res Treat       Date:  2021-10-08       Impact factor: 4.872

2.  The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies.

Authors:  Chang Yang; Ge Lou; Wei-Lin Jin
Journal:  Signal Transduct Target Ther       Date:  2021-06-03

3.  Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy.

Authors:  Jiayi Ye; Bo Hou; Fangmin Chen; Shunan Zhang; Muya Xiong; Tianliang Li; Yechun Xu; Zhiai Xu; Haijun Yu
Journal:  Acta Pharm Sin B       Date:  2021-09-25       Impact factor: 14.903

Review 4.  Neoantigens and NK Cells: "Trick or Treat" the Cancers?

Authors:  Dan Lv; Muhammad Babar Khawar; Zhengyan Liang; Yu Gao; Haibo Sun
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.